NCT05671094

Brief Summary

Current literature on prehabilitation is broad and heterogenous. Ploussard et al initiated a multimodal one-day prehabilitation program in patients before robotic radical prostatectomy involving urology nurses, anaesthetic nurses, oncology nurse specialists, anesthesiologists, dieticians, physiotherapists etc, and observed significant improvement in terms of reduction in length of stay, blood loss, and operative time, and an increase in the proportion of ambulant surgery. Santa Mina et al observed that patients following a home-based moderate-intensity exercise prehabilitation program prior to radical prostatectomy were more fit i.e have a greater score on the 6 minutes' walk test, four weeks postoperatively compared to a control group. Regrettably, this study couldn't demonstrate a difference in length of stay or complication rate. To date, evidence for efficacy of prehabilitation in gynaecological cancer patients is limited. Several reviews and a meta-analysis indicate that the level of evidence suggesting that prehabilitation may improve postoperative outcomes is low. Moreover, there is a wide variability in applied preoperative prehabilitation programs i.e, with a uni- or multimodal approach, home-based or supervised, differences in intensity and a variety of outcomes. Therefore, there is a need for randomized controlled trials with low risk of bias and clearly defined outcome parameters to clarify the potential benefit of prehabilitation for patients Hence, the primary goal of this randomized pilot study is to determine the feasibility of the implementation of a multimodal prehabilitation program in patients undergoing robotic oncologic urological or gynaecological surgery in a Belgian tertiary center in terms of protocol adherence and recruitment rate.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

January 13, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 19, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

11 months

First QC Date

December 20, 2022

Last Update Submit

May 12, 2025

Conditions

Keywords

Prehabilitation

Outcome Measures

Primary Outcomes (2)

  • Adherence rate to the prehabilitation program

    Protocol adherence is defined as excellent if 80% of patients were fully adherent to the prehabilitation program. Full adherence is defined as adherence to all 4 different prehabilitation program components (see above). Adherence to the physical component will be assessed by the physical medicine and rehabilitation physician, responsible for this component. Adherence to the nutrition component will be assessed by the dietician, responsible for coaching of patients with nutrition. The other 2 components will be assessed by the study team at the end of the program.

    throughout study completion, an average of 1 year

  • Recruitment rate

    Recruitment rate is defined as excellent if 40 patients can be enrolled in this study in a time frame of 6 months.

    6 months after the start of the study

Secondary Outcomes (9)

  • Incidence of Postoperative Cognitive Disorder

    3 months after surgery

  • Assessment of Patient Recovery

    Baseline (before surgery) and 6 weeks after surgery.

  • Assessment of quality of recovery

    Baseline (before surgery) and 24 hours after surgery

  • Hospital length of stay

    through study completion, an average of 3 months

  • Assessment of amount of red blood cell transfusion

    throughout study completion, an average of 3 months

  • +4 more secondary outcomes

Study Arms (2)

Control group

NO INTERVENTION

Standard of care, i.e no specific program prior to surgery.

Prehabilitation group

EXPERIMENTAL

A multimodal prehabilitation program including 4 different components (physical, cognitive, nutritional and stress reduction prehabilitation) will be proposed to patients in order for them to participate during four to two weeks pre-operatively.

Behavioral: Prehabilitation

Interventions

PrehabilitationBEHAVIORAL

Physical, mental, stress reducing and dietary prehabilitation programme, 4 to 2 weeks before surgery

Prehabilitation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (≥ 18 years)
  • Competent to provide informed consent
  • Undergoing robotic oncological urological or gynaecological surgery in ≥ 30 days from enrollment.
  • Fluent in Dutch

You may not qualify if:

  • Premorbid conditions or orthopedic impairments with contraindications to exercise
  • Cognitive disabilities defined as evolutive neurological or neurodegenerative disease
  • ASA score 4 or higher or patient under palliative care
  • Expected length of stay at hospital \< 48 hours
  • Patient under tutorship or curatorship
  • Pregnant or breast-feeding woman
  • Absence of informed consent or request to not participate to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessa Hospital

Hasselt, Limburg, 3500, Belgium

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Preoperative Exercise

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Perioperative CarePatient CareTherapeuticsSurgical Procedures, OperativeExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All treating physicians including surgical team, attending anesthetist and surgeon, all researcher assessing outcomes (i.e. study nurse + surgeon) and the data-managers will be blinded for group allocation until the end of the study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 20, 2022

First Posted

January 4, 2023

Study Start

January 13, 2023

Primary Completion

December 19, 2023

Study Completion

December 31, 2024

Last Updated

May 14, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations